Analyzing brain waveforms using neuroimaging big data helps improve diagnosis accuracy
A team of researchers from Osaka University and The University of Tokyo developed MNet, an automatic diagnosis system for neurological diseases using magnetoencephalography (MEG) (Figure 1), demonstrating the possibility of making automatic neurological disease diagnoses using MEG. Their research results were published in Scientific Reports.
MEG and electroencephalography (EEG) are essential for diagnosing neurological diseases such as epilepsy. MEG allows for the acquisition of detailed temporal-spatial patterns of human brain activity through the measurement of electro-magnetic field associated with neural activity, extracting detailed time-series signals from 160 sensors. Although information obtained from these tests is important for diagnosis, time and expertise are necessary for reading and analyzing, and abnormal waveform patterns may be missed.
Deep Neural Network (DNN), also known as deep learning, is a subset of machine learning in artificial intelligence (AI) and has drawn attention in recent years as a means for classifying data on various images, videos, and sounds at a high accuracy through a machine learning process using big data.
The AI-powered automatic classification system MNet, which utilizes DNN as a computational framework, is based on a neural network called EnvNet (end-to-end convolutional neural network for environmental sound classification) and can be trained to extract and learn features of neuroimaging signals unique to various neurological diseases from a massive amount of time-series neuroimaging data.
The team expected that the use of DNN would allow for the system to learn the characteristics of neurological diseases from many signals and classify patients with neurological diseases more accurately than conventional methods using waveforms.
With MNet, they tried to classify neuroimaging big data on 140 patients with epilepsy, 26 patients with spinal cord injuries, and 67 healthy subjects. The trained MNet succeeded in classifying healthy subjects and those with the two neurological diseases with an accuracy of over 70% and patients with epilepsy and healthy subjects with an accuracy of nearly 90%. The classification accuracy was significantly higher than that obtained by a support vector machine (SVM), a conventional general machine learning method based on waveforms (relative band powers of EEG signal). Moving forward, this technique will be used for diagnosis of various neurological diseases, evaluation of severity, prognosis, and efficacy of treatment.
“Machine learning is constantly advancing, with new techniques being developed all the time. However, no matter how much analytical methods advance, if the quality of underlying data is poor, a sharp distinction cannot be drawn. We carried out the process of machine learning by utilizing DNN, which processed big data mainly from the Osaka University Hospital Epilepsy Center. We’d like to increase the number and the types of diseases to be diagnosed without sacrificing quality of data so that our technique will be helpful in clinical practice,” says researcher Jo Aoe of Osaka University.
The Latest on: Automatic diagnosis system
via Google News
The Latest on: Automatic diagnosis system
- TAU team develops automatic tool to help drs choose best cancer treatmenton August 12, 2020 at 9:18 am
According to Prof. Tamir Tuller, the technology automatically deciphers cancer genomes or mutations, which cannot be interpreted by the human brain alone or by existing models.
- Food Diagnostics Market worth $19.2 billion by 2025 - Exclusive Report by MarketsandMarkets™on August 12, 2020 at 5:30 am
According to the new market research report "Food Diagnostics Market by Type (Systems, Test Kits, Consumables), Test Type (Safety & ...
- Canon Medical Systems USA, Inc. Partners With Zebra Medical Vision to Further Expand AI Offeringson August 11, 2020 at 3:53 am
Building on its commitment to providing customers with Artificial Intelligence (AI) solutions that can be utilized across modalities in routine care, ...
- Partially automated whole-genome sequencing reanalysis of previously undiagnosed pediatric patients can efficiently yield new diagnoseson August 11, 2020 at 2:12 am
To investigate the diagnostic and clinical utility of a partially automated reanalysis pipeline, forty-eight cases of seriously ill children with suspected genetic disease who did not receive a ...
- Sysmex America Signs Exclusive Agreement to Distribute and Service Siemens Healthineers Automated Urine Chemistry Analyzeron August 10, 2020 at 6:00 am
The CLINITEK Novus Automated Urine Analyzer combines ... Its innovative hematology, urinalysis, information systems and flow cytometry testing technology are reshaping the world of diagnostics. As ...
- A longitudinal footprint of genetic epilepsies using automated electronic medical record interpretationon August 9, 2020 at 7:31 pm
Childhood epilepsies have a strong genetic contribution, but the disease trajectory for many genetic etiologies remains unknown. Electronic medical record (EMR) data potentially allow for the analysis ...
- Accelerate Diagnostics: 2Q Earnings Snapshoton August 7, 2020 at 2:20 am
TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Thursday reported a loss of $19.2 million in its second quarter. The Tucson, Arizona-based company said it had a loss of 35 cents per share.
- Sight Diagnostics Raises $71M To Accelerate Global Expansion of its FDA 510(k) Cleared, CE Marked Finger-prick Blood Analyzeron August 5, 2020 at 8:15 am
Sight DiagnosticsⓇ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raise ...
- Thermo Fisher Launches Highly Automated PCR Solution For COVID-19 Testing - Quick Factson August 5, 2020 at 6:07 am
(RTTNews) - Thermo Fisher Scientific Inc. (TMO) said Wednesday it has unveiled a new highly automated, real-time PCR solution designed to analyze ...
- Thermo Fisher Scientific’s COVID-19 Response Continues to Expand with New High-Throughput Automated Testing Solutionon August 5, 2020 at 5:00 am
PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in ...
via Bing News